Connect Biopharma Holdings Ltd banner

Connect Biopharma Holdings Ltd
NASDAQ:CNTB

Watchlist Manager
Connect Biopharma Holdings Ltd Logo
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Watchlist
Price: 2.28 USD -2.15% Market Closed
Market Cap: $143.5m

Wall St Price Targets

CNTB Price Targets Summary
Connect Biopharma Holdings Ltd

Wall Street analysts forecast CNTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTB is 7.4 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Lowest Forecast
Price Target
4.04 USD
77% Upside
Average Forecast
Price Target
7.4 USD
224% Upside
Highest Forecast
Price Target
10.5 USD
361% Upside
Connect Biopharma Holdings Ltd Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
40% Upside

Revenue
Forecast

N/A
Past Growth
185% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
185% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 8 years is 185%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
51%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
51%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CNTB's stock price target?
Price Target
7.4 USD

According to Wall Street analysts, the average 1-year price target for CNTB is 7.4 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

What is the Revenue forecast for Connect Biopharma Holdings Ltd?
Projected CAGR
185%

The compound annual growth rate for Revenue over the next 8 years is 185%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett